Global Foot and Mouth Disease (FMD) Vaccines Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global Foot and Mouth Disease (FMD) Vaccines Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Foot and Mouth Disease (FMD) vaccines are vaccines that provide active acquired immunity to Foot and Mouth Disease (FMD). Foot and Mouth Disease (FMD) is a highly contagious viral disease that primarily affects cloven-hooved livestock and wildlife like cattle, pigs, sheep and goats.

Market Overview:

The latest research study on the global Foot and Mouth Disease (FMD) Vaccines market finds that the global Foot and Mouth Disease (FMD) Vaccines market reached a value of USD 1735.87 million in 2022. It’s expected that the market will achieve USD 2572.51 million by 2028, exhibiting a CAGR of 6.78% during the forecast period.

Region Overview:

Geographically, Asia Pacific held the largest market share – 75.45% in 2022.

Company Overview:

Jinyu Group is one of the major players operating in the Foot and Mouth Disease (FMD) Vaccines market, holding a share of 14.72% in 2023.

Jinyu Group

Jinyu Baoling Biopharmaceutical Co., Ltd. is affiliated with Inner Mongolia Jinyu Group Co., Ltd. (JINYU GROUP, stock code 600201). It is one of the backbone enterprises designated by the Ministry of Agriculture to produce domestic animal foot-and-mouth disease vaccine.

Boehringer Ingelheim

Boehringer Ingelheim is a global group of companies embracing many cultures and diverse societies. The company concentrates on developing innovative therapies that can extend patients’ lives. In animal health, Boehringer Ingelheim stands for advanced prevention.

Segmentation Overview:

Among different product types, Conventional Vaccines segment is anticipated to contribute the largest market share in 2028.

Conventional Vaccines

At present, conventional FMD vaccines can prevent clinical diseases and have a short period of protection (about 6 months). Frequent revaccinations are often required for preventive control, and vaccination cannot induce rapid protection against challenges or prevent carriers. State development.

Emergency Vaccines

Foot-and-mouth disease (FMD) emergency vaccine is a high-potency vaccine (PD_ (50) ≥ 6), which has a wide range of immune cross-sections. It can induce a protective immune response 3 to 4 days after inoculation and can prevent Or reduce the virus's replication and excretion in other parts of the throat that are easy to hide the virus, and the formation of persistent infection. The persistence of the antibodies induced is longer than that of traditional inactivated vaccines.

Application Overview:

The market's largest segment by application is the segment Cattle, with a market share of 67.13% in 2022.

Key Companies in the global Foot and Mouth Disease (FMD) Vaccines market covered in Chapter 3:

Shen Lian
Jinyu Group
Boehringer Ingelheim
Ceva Santé Animale
ME VAC
BIGVET Biotech
Indian Immunologicals
Tecon Biology Co.,ltd
LIMOR
CAHIC
Biogenesis Bagó
Cavet Bio
Brilliant Bio Pharma
MSD Animal Health

In Chapter 4 and Chapter 14.2, on the basis of types, the Foot and Mouth Disease (FMD) Vaccines market from 2018 to 2029 is primarily split into:

Conventional Vaccines
Emergency Vaccines

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Foot and Mouth Disease (FMD) Vaccines market from 2018 to 2029 covers:

Cattle
Pigs
Sheep and Goats

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)